文献速递前列腺癌

术后淋巴结阳性前列腺癌且术前常规影像阴性患者辅助放疗与观察联合或不联合早期挽救性放疗的多中心研究

Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter Study.
PubMed 文献 · J Urol · 2025-02-10

该多中心回顾性研究纳入1103例根治术后cN0M0 pN1前列腺癌患者,比较辅助放疗与观察(联合或不联合早期挽救性放疗)的生存结局。基于pT分期、ISUP分级和阳性淋巴结数建立两分类风险模型,高危组接受辅助放疗者总生存率高于观察组(92% vs 84%,P=0.006)。

要点

  • ≥3枚阳性淋巴结(HR 2.03,95%CI 1.22-3.37,P=0.006)和ISUP 5(HR 1.92,95%CI 1.15-3.18,P=0.01)与全因死亡率升高相关。
  • 观察组低-中危患者7年无病生存率为27%(95%CI 20.4-36),高危患者为11%(95%CI 6.7-17)。
  • 高危组辅助放疗较观察提高总生存率(92%,95%CI 87-96 vs 84%,95%CI 77-90,P=0.006),交互项分析HR 0.28(95%CI 0.09-0.84,P=0.024)。

核心结论

  • 在cN0M0 pN+前列腺癌中,仅基于不良预后因素判定的高危患者,辅助放疗较观察联合或不联合早期挽救性放疗带来生存获益。
  • 作者建立了风险模型以指导该情境下的临床决策。

研究设计与样本

  • 多中心回顾性研究,纳入2000-2021年间18家转诊中心1103例根治术后cN0M0 pN1前列腺癌患者。
  • 采用Kaplan-Meier曲线和Cox比例风险模型进行分析。
  • 基于pT分期、ISUP分级和阳性淋巴结数建立两分类风险模型。

主要发现

  • 670例(61%)患者ISUP分级为4-5,阳性淋巴结数中位数为1枚。
  • 多因素分析显示≥3枚阳性淋巴结(HR 2.03,95%CI 1.22-3.37,P=0.006)和ISUP 5(HR 1.92,95%CI 1.15-3.18,P=0.01)与全因死亡率升高相关。
  • 观察组中,低-中危患者7年无病生存率为27%(95%CI 20.4-36),高危患者为11%(95%CI 6.7-17)。
  • 高危组辅助放疗总生存率为92%(95%CI 87-96),观察组为84%(95%CI 77-90),P=0.006。
  • 交互项分析中,辅助放疗对高危患者死亡率的保护效应HR为0.28(95%CI 0.09-0.84,P=0.024)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our goals were to assess the survival outcomes of adjuvant radiation therapy (aRT) vs observation with or without early salvage radiation therapy for cN0M0 pN1 prostate cancer (PCa) and to create a model for clinical decision-making. MATERIALS AND METHODS: We retrospectively identified 1103 patients with cN0M0 PCa with pN1 PCa after surgery (2000-2021) at 18 referral centers. Kaplan-Meier curves and Cox proportional hazards models were used. RESULTS: Overall, 670 patients (61%) had International Society of Urological Pathology (ISUP) 4 to 5, and the median number of positive nodes was 1. On multivariable analyses, ≥ 3 positive nodes (HR, 2.03, 95% CI, 1.22-3.37; P = .006) and ISUP 5 (HR, 1.92, 95% CI, 1.15-3.18; P = .01) were associated with an increased all-cause mortality. Based on pT stage, ISUP, and positive nodes, a 2 risk categories model was created. In men undergoing observation, 7-year disease-free survival was 27% (95% CI, 20.4-36) for low- to intermediate-risk and 11% (95% CI, 6.7-17) for high-risk patients; aRT had higher overall survival rates in the high-risk group (92%; 95% CI, 87-96 vs observation 84%, 95% CI, 77-90; P = .006). In interaction term analyses, aRT confirmed its protective effect on mortality in high-risk patients (HR, 0.28, 95% CI, 0.09-0.84, P = .024). Results were comparable when excluding men with PSA persistence. CONCLUSIONS: In cN0M0 pN+ PCa, aRT yields a survival benefit compared with observation with or without early salvage radiation therapy only in men with a high-risk disease based on unfavorable prognostic factors. We created a risk model to guide clinical decision-making in this setting.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Marra G, Barletta F, Scuderi S, et al. Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter Study. J Urol. 2025. PMID: 39929079. doi:10.1097/JU.0000000000004468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。